A Single Oxidative Tweak Makes Eye Proteins Prone to Clumping
Almost everyone who lives long enough will develop cataracts. The lens of the eye clouds gradually, over decades, until vision blurs and eventually fails. Surgery can fix it once it gets bad enough, but understanding why it happens at all - at the molecular level, before any cloudiness is visible - has proven surprisingly elusive.
Part of the reason is technical. The proteins responsible for lens clarity are meant to last a lifetime. The eye lens cannot replace damaged proteins the way most tissues do, so researchers studying how those proteins degrade over time need to work with the actual accumulated changes of aging rather than fresh, unmodified material. That makes it hard to isolate the effect of any single chemical modification.
Engineering a specific kind of damage
A team at UC Irvine found a way around that problem. Using a technique called genetic code expansion - which allows scientists to build proteins with particular chemical features written in from the start - they introduced a single oxidative modification at one specific location in a lens protein called gamma-S-crystallin.
Oxidative damage to crystallins is known to accumulate in aging eyes, driven partly by decades of ultraviolet light exposure. The UC Irvine approach let the team isolate that one type of change and ask: what exactly does it do?
"GCE lets us make very precise changes to a protein," said lead author Yeonseong (Catherine) Seo, a PhD candidate in chemistry at UC Irvine. "We used it to copy one kind of damage that shows up in age-related cataracts and see exactly what it does."
The protein looks fine - until it doesn't
The oxidized protein remained folded and structurally stable under normal conditions. It behaved, in most respects, like an unmodified protein. But when the researchers applied heat stress, the modified protein clumped together far more readily than its unmodified counterpart.
"The protein doesn't fall apart right away," Seo explained. "It just becomes a little more likely to interact with its neighbors, and over time that can lead to clumping."
That is, in miniature, what age-related cataracts are: a gradual accumulation of protein aggregates that scatter light instead of transmitting it cleanly. If even a subtle chemical modification can meaningfully increase a protein's tendency to aggregate under stress, it does not take many decades of UV exposure to start shifting the balance.
How proteins breathe - and what happens when they breathe wrong
The team is now investigating the mechanism behind the increased aggregation tendency. Proteins are not static structures. They flex and shift constantly, and those movements are part of how they function - and part of how they protect themselves. Vulnerable regions are normally kept tucked away by the protein's natural motion patterns.
"We're essentially watching how the protein breathes," Seo said. "If certain parts start moving more than they should, it can briefly open up areas that are normally protected."
The hypothesis is that the oxidative modification alters those dynamics subtly, making the protein periodically expose regions that then stick to neighboring proteins. Over years and decades, those brief sticky moments add up.
Understanding that mechanism matters because it points toward potential prevention strategies. If specific motion patterns are responsible for aggregation, it may eventually be possible to design small molecules that stabilize those dynamics - a non-surgical intervention to slow cataract formation before it affects vision.
"Almost everyone who lives long enough will get age-related cataracts," said corresponding author Rachel Martin, professor of chemistry at UC Irvine. "GCE enables us to study specific changes that happen with proteins in the aging lens, furthering our understanding of what causes cataracts at the molecular level. Understanding the loss of function that comes with aging could lead to non-surgical treatments or improved artificial lenses in the future."
The study was published in Biophysical Reports. Key funding came from the National Institutes of Health.